Member Login
  1. Tag
    2. /
  2. AstraZeneca
    3. /

AstraZeneca

Top Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

9 stocks that Fools have been buying!

| The Motley Fool Staff

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Illustration of flames over a black background
Investing Articles

Just released: April’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

| Mark Rogers

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

5 stocks that Fools think are overvalued

| The Motley Fool Staff

There are a few famous value investors who spring to mind that might take one look at these stocks, and…

Read more »

Black father and two young daughters dancing at home
Investing Articles

Just released: our 3 top small-cap stocks to buy before May [PREMIUM PICKS]

| Mark Rogers

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

“The last FTSE 100 stock I’d sell in a recession is…”

| The Motley Fool Staff

It's well worth considering some recession-resiliant stocks as part of a diversifed portfolio. Here, our free-site writers offer up their…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to buy in April [PREMIUM PICKS]

| Mark Rogers

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

“The last holding I’d want to sell in my Stocks and Shares ISA is…”

| The Motley Fool Staff

Happy New Tax Year, to all Stocks and Shares ISA owners! The £20,000 allowance has reset -- will you be…

Read more »

Investing Articles

Recently released: our latest Hidden Winners ‘sell’ recommendation [PREMIUM PICKS]

| Mark Rogers

Here at The Motley Fool, we don’t hide the fact that ‘selling’ is part of the investment equation.

Read more »

Recent AstraZeneca News

Investing Articles

3 FTSE 100 stocks I’d never sell

| Alan Oscroft

There are some FTSE 100 (INDEXFTSE:UKX) shares that really do deserve to be held forever.

Read more »

Investing Articles

Is this the FTSE 100’s top growth stock?

| G A Chester

This FTSE 100 (INDEXFTSE: UKX) unsung hero good could be a top growth pick, says G A Chester.

Read more »

Investing Articles

3 great income stocks I’d buy today

| Harvey Jones

If you are looking for a base rate busting income these three FTSE 100 companies are a great place to…

Read more »

Investing Articles

A FTSE 100 giant with 20% upside to consider

| Rupert Hargreaves

This blue chip could have a possible upside of 20%.

Read more »

Investing Articles

Are shares in GlaxoSmithKline plc now in bargain territory?

| Paul Summers

Paul Summers casts his eyes over today's results from pharmaceutical giant GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Should you buy or sell AstraZeneca plc after FY sales fall 5%?

| Roland Head

Roland Head reviews 2016 results from AstraZeneca plc (LON:AZN) and asks whether the firm's ambitious goals deserve a buy rating.

Read more »

Investing Articles

After revenue jumps 60%, is Oxford Biodynamics plc a buy?

| Rupert Hargreaves

Could Oxford Biodynamics PLC (LON: OBD) be London's next super growth stock?

Read more »

Investing Articles

2 hot FTSE 100 dividend stocks I’d buy in February

| Peter Stephens

These two shares offer excellent income potential.

Read more »

Investing Articles

Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc?

| G A Chester

Are Capita plc (LON:CPI) and AstraZeneca plc (LON:AZN) poor investments today?

Read more »

Investing Articles

Why I see 50% upside in this pharmaceutical firm in 2017

| Bilaal Mohamed

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year.

Read more »

Investing Articles

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

| Peter Stephens

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Neil Woodford’s favourite stock set to outperform in 2017?

| Rupert Hargreaves

Neil Woodford loves this company, but should you be buying?

Read more »

Investing Articles

2 healthcare stocks that could make you rich in 2017

| Peter Stephens

These two companies offer bright futures at fair valuations.

Read more »

Investing Articles

My 3 top dividend stocks for Christmas

| Alan Oscroft

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year.

Read more »

Investing Articles

Why Eco Animal Health Group Plc is set to outperform AstraZeneca plc in 2017

| Peter Stephens

Eco Animal Health Group Plc (LON: EAH) has more appeal than AstraZeneca plc (LON: EAH).

Read more »

Investing Articles

Why I believe these 3 stocks will struggle in 2017

| Rupert Hargreaves

These three companies are in danger of generating losses for investors next year.

Read more »

Investing Articles

3 cheap blue chips for December

| Paul Summers

Are these Footsie favourites now unmissable bargains?

Read more »

Investing Articles

4 dividend stocks to put on your 2017 shopping list

| Royston Wild

Royston Wild reveals a cluster of London stocks with exceptional dividend potential.

Read more »

Investing Articles

Is ReNeuron Group plc a better buy than AstraZeneca plc?

| Peter Stephens

Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)?

Read more »

Investing Articles

These 3 FTSE 100 stocks are ridiculously cheap!

| Royston Wild

Royston Wild discusses three FTSE 100 (INDEXFTSE: UKX) dealing at rock-bottom prices.

Read more »

Investing Articles

Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?

| Peter Stephens

Will AstraZeneca plc (LON: AZN) or GlaxoSmithKline plc (LON: GSK) soar over the medium-to-long term?

Read more »

Investing Articles

Are these 2 stocks the income heroes your portfolio needs?

| Harvey Jones

These two stocks pay income of more than 5% a year. Harvey Jones examines whether this rate of return is…

Read more »

Investing Articles

Should you dump AstraZeneca plc and buy BTG plc after 10% sales rise?

| Peter Stephens

Does BTG plc (LON: BTG) offer superior growth potential to AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Clinigen Group plc vs AstraZeneca plc: which is the hotter healthcare stock?

| Royston Wild

Royston Wild considers the investment potential of medicine mammoths Clinigen Group plc (LON: CLIN) and AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why AstraZeneca plc may still not be cheap enough to beat this upstart

| Roland Head

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative.

Read more »

Investing Articles

Should you invest in pills or joints?

| G A Chester

Which of these stocks should be on your shopping list today?

Read more »

Investing Articles

2 firms to hold until you retire and beyond

| Kevin Godbold

Brexit looks like a sideshow for these enduring businesses.

Read more »

Investing Articles

These FTSE 100 stocks sank in October. Time to stock up?

| Royston Wild

Royston Wild runs the rule over two recent FTSE 100 (INDEXFTSE: UKX) losers.

Read more »

Investing Articles

The Good, the Bad and the Ugly of pharma stocks

| Bilaal Mohamed

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector.

Read more »

Investing Articles

Should you buy this stock after it reports a 27% rise in revenue?

| Peter Stephens

Is this company set to soar after positive results?

Read more »

Investing Articles

Forget short-term pain! Buy these FTSE 100 stars for long-term gain

| Royston Wild

Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors.

Read more »

Investing Articles

These FTSE 100 beauties are just too cheap to miss!

| Royston Wild

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) firecrackers trading far, far too cheaply.

Read more »

Investing Articles

These dividend stocks won’t yield 4%+ forever

| Peter Stephens

Getting a 4%+ yield from these shares beats savings accounts, but may not be available for much longer.

Read more »

Investing Articles

These two FTSE 100 dividends stars still look cheap

| Rupert Hargreaves

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued.

Read more »

Investing Articles

Do these 3 low yielders offer high growth prospects?

| Harvey Jones

A sky-high yield isn't everything these days, is it? Harvey Jones investigates.

Read more »

Investing Articles

Is this a better healthcare buy than AstraZeneca plc after today’s update?

| Peter Stephens

Will this healthcare stock keep beating AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

| Alan Oscroft

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN)…

Read more »

Investing Articles

These two large caps look seriously undervalued

| Rupert Hargreaves

These two large caps could be the most undervalued in the FTSE 100.

Read more »

Investing Articles

Should you pile into this healthcare stock after today’s update?

| Peter Stephens

Is this healthcare stock a 'must-buy'?

Read more »

Investing Articles

Can you really trust these Footsie big yielders to pay out?

| Royston Wild

Royston Wild discusses the payout prospects of three FTSE 100 dividend stocks.

Read more »